Navigation Links
Quantum Materials Achieves 95% Quantum Yield by Automated Quantum Dot Production

SAN MARCOS, Texas, Aug. 6, 2014 /PRNewswire/ -- Quantum Materials Corp (OTCQB:QTMM) (QMC) today announced achieving a calculated 95% Quantum Yield (QY) for Green Tetrapod Quantum Dots (TQD) manufactured by QMC's proprietary automated mass-production system. The Full-Width Half-Maximum achieved was a narrow 36 nanometers with tunable emission from 530 to 550nm. Potential clients are currently evaluating these high-performance TQD.

QMC is pleased to offer high quantum yield quantum dots with reproducible FWHM uniformity, reliable system redundancy, and the ability to scale production to any quantity necessary for industrial purposes with modest capital expense (CAPEX) and low ongoing manufacturing costs. QMC's ability to achieve economies of scale with automated production is unmatched and offers supply security and dependable cost forecasting in joint ventures planning very large quantum dot product rollouts.  QMC is planning additional capacity on the order of multi-kilograms per day to meet project needs that are being defined. QMC previously stated that capacity could be expanded sufficient to support the entire display industry converted to quantum dot 4K and 8K displays. According to market researcher IHS, demand for QD-LCD displays is projected to jump to 87.3 million units by 2020 (a CAGR of 109% between 2013 and 2020) as QD prices decrease and a reliable and uniform quantum dot supply is assured for large production runs. QMC is positioned to capture QD-LCD market share.

In solar photovoltaics, Solterra Renewable Technologies, a QMC wholly owned subsidiary, calculates just one Solterra Quantum Dot Solar Cells (QDSC) Plant can be scaled up to produce 1000 Megawatts per year of printed solar cells using its own dedicated production of QMC quantum dots.  A Solterra QDSC facility would rely on low CAPEX for both the QD production as well as low startup costs for the solar cell equipment.  Combined automated production of QD and QDSC allow a cost goal of under 12¢ per kWh, the present estimated residential electricity rate in the U.S. In comparison, the four largest solar projects in 2012 in the U.S. are planning to produce 1788Mw at a CAPEX of $11.5B ($6.5MM/MW) with Federal Subsidies of $5.7B and U.S. taxpayer liability in loan guarantees. Typically, due to the need to pay down the loan, a purchase agreement by a Public Utility or local government must require a higher rate to be paid than 12¢ per kWH, which is passed on to the public in the form of higher bills. Solterra's goal is to establish regional or national QDSC plants at a fraction of the above CAPEX entirely by the private sector, without federal subsidies, and a cost goal of under 12¢ per kWh.

Quantum Materials is also developing non-heavy metal (Cadmium-Free) quantum dots using modified synthesis recipes and automated manufacturing processes.

About Quantum Materials Corp

Quantum Materials Corp. develops and manufactures Tetrapod Quantum Dots for use in medical, display, solar energy and lighting applications through its patent-pending volume production process. Quantum dots enable a new level of engineered performance in a wide array of consumer and industrial products. QMC's volume manufacturing methods enable consistent quality and scalable cost reductions to drive innovative discovery to commercial success. (

Solterra Renewable Technologies

Wholly-owned subsidiary Solterra Renewable Technologies develops sustainable solar technology by replacing silicon wafer-based solar cells with high-production, low-cost, efficient and flexible thin-film quantum dot solar cells.  (

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that involve risks and uncertainties concerning business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's EDGAR System at or We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

Art Lamstein
Director of Marketing
Quantum Materials Corp.

Rich Schineller

Photo - 
Logo -

SOURCE Quantum Materials Corp.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board
2. Study Confirms Efficacy of Innovative Therapies Quantum Negative Pressure Wound Therapy (NPWT) in Enhancing Wound Healing
3. Quantum Materials Engineers Tetrapod Quantum Dots to Improve Diagnostic Accuracy of Biomedical Assays and Devices
4. Unique University - Industry Partnership to Spur Tetrapod Quantum Dot Commercialization
5. Quantum Materials Establishes Milestone as First Company to Deliver Tetrapod Quantum Dot Samples to LCD Display Manufacturer
6. Quantum Materials Tetrapod Quantum Dots Break Kashas Rule: Enhanced Performance Enables Commercialization of Novel Discovery
7. Quantum Materials Corp Moves Quantum Dot Labs to STAR Park, San Marcos, TX
8. Quantum Materials Corp selects Austin, Texas for new R&D Labs
9. Quantum Materials Corporation Supplies Tetrapod Quantum Dots to U.S. Government Researchers
10. Block Engineering Partners with SKAE and Pembroke for Quantum Cascade Laser Instrument Sales
11. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
Post Your Comments:
(Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
(Date:12/1/2015)... 2015 During the recent 2015 Transcatheter ... Francisco, CA , Medinol Ltd. continued to ... During a satellite symposium, "The BioNIR eDES: The ... Restenosis", a renowned physician panel discussed the key ... Coronary Stent System and the Medinol eDES Coronary ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 01, 2015 , ... Florida Hospital Tampa is the first health care provider in ... of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via the Maestro® System, ... mass index (BMI) of at least 40 to 45 kg, or a BMI of at ...
(Date:12/1/2015)... ... ... Dr. Paul Vitenas, one of the top cosmetic surgeons in Texas ... the Best Single Physician Practice in the nation. Dr. Vitenas and his practice were ... the industry publication. , Dr. Vitenas said he was very honored to receive ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... ... December 01, 2015 , ... For ... mark the film for accurate interpretation by the radiologist. The marking utensils are ... from Sacramento, Calif., has found a way to alleviate this problem. , He ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., December ... a fixed price per sprint agile development contract to support the National Geospatial-Intelligence ... five years, provides software engineering, infrastructure, as well as operations and sustainment support ...
Breaking Medicine News(10 mins):